Analyst Ratings for IBM (IBM) [Buys]
IBM Rating Summary
IBM Price Target Summary
- Highest: $251.00 (Topeka Capital)
- Lowest: $197.00 (JPMorgan)
- Average: $225.35
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$225.35 (+8.1%)
Avg. $ Target:
$225.35 (+8.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/10/2013 | UBS | Upgrade | Buy (Neutral) |
235.00 (N/A) |
209.22 | 208.44 | -0.37% | Details |
| 12/21/2012 | Topeka Capital » Updated 3/28/2013 |
New Coverage | Buy (N/A) |
251.00 (N/A) |
194.77 | 208.44 | 7.02% | Details |
| 10/9/2012 | Citi | New Coverage | Buy (N/A) |
250.00 (N/A) |
209.82 | 208.44 | -0.66% | Details |
| 9/4/2012 | Barclays » Updated 10/17/2012 |
Upgrade | Overweight (Equalweight) |
240.00 (N/A) |
194.85 | 208.44 | 6.97% | Details |
| 2/7/2012 | Sterne Agee » Updated 4/19/2013 |
New Coverage | Buy (N/A) |
230.00 (N/A) |
192.82 | 208.44 | 8.1% | Details |
| 11/3/2011 | Evercore Partners | New Coverage | Overweight (N/A) |
210.00 (N/A) |
183.92 | 208.44 | 13.33% | Details |
| 8/15/2011 | Goldman Sachs » Updated 4/19/2013 |
Upgrade | Buy (N/A) |
220.00 (233.00) |
168.20 | 208.44 | 23.92% | Details |
| 2/8/2011 | Capstone Investments | New Coverage | Buy (N/A) |
N/A (N/A) |
164.82 | 208.44 | 26.47% | Details |
